Does KETOCONAZOLE Cause Product use in unapproved indication? 421 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 421 reports of Product use in unapproved indication have been filed in association with KETOCONAZOLE (Ketoconazole). This represents 7.6% of all adverse event reports for KETOCONAZOLE.
421
Reports of Product use in unapproved indication with KETOCONAZOLE
7.6%
of all KETOCONAZOLE reports
9
Deaths
26
Hospitalizations
How Dangerous Is Product use in unapproved indication From KETOCONAZOLE?
Of the 421 reports, 9 (2.1%) resulted in death, 26 (6.2%) required hospitalization, and 1 (0.2%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for KETOCONAZOLE. However, 421 reports have been filed with the FAERS database.
What Other Side Effects Does KETOCONAZOLE Cause?
Drug ineffective (1,326)
Off label use (657)
Pruritus (559)
Product use issue (428)
Alopecia (375)
Therapeutic response unexpected (317)
Psoriasis (312)
Rash (267)
Hair texture abnormal (255)
Skin exfoliation (225)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which KETOCONAZOLE Alternatives Have Lower Product use in unapproved indication Risk?
KETOCONAZOLE vs KETOPROFEN
KETOCONAZOLE vs KETOPROFEN LYSINE
KETOCONAZOLE vs KETOROLAC TROMETHAMINE
KETOCONAZOLE vs KETOROLAC\KETOROLAC TROMETHAMINE
KETOCONAZOLE vs KETOTIFEN